Candidate risk factors for cardiovascular disease in CKD.
Semin Nephrol. 2006 Jan;26(1):1-2
Causes of hyperhomocysteinemia in patients with chronic kidney diseases.
Semin Nephrol. 2006 Jan;26(1):3-7
Genetic aspects of hyperhomocysteinemia in chronic kidney disease.
Semin Nephrol. 2006 Jan;26(1):8-13
Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.
Semin Nephrol. 2006 Jan;26(1):14-9
Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.
Semin Nephrol. 2006 Jan;26(1):20-3
Therapy of hyperhomocysteinemia in chronic kidney disease.
Semin Nephrol. 2006 Jan;26(1):24-7
Effect of different hemodialysis regimens on genomic damage in end-stage renal failure.
Semin Nephrol. 2006 Jan;26(1):28-32
Vascular calcification in uremic conditions: new insights into pathogenesis.
Semin Nephrol. 2006 Jan;26(1):33-7
Management of vascular calcification in CKD patients.
Semin Nephrol. 2006 Jan;26(1):38-41
Vascular erectile dysfunction in chronic renal failure.
Semin Nephrol. 2006 Jan;26(1):42-5
Coagulation disorders in uremia.
Semin Nephrol. 2006 Jan;26(1):46-51
Newer aspects of carnitine metabolism in uremia.
Semin Nephrol. 2006 Jan;26(1):52-5
Depression in chronic kidney disease.
Semin Nephrol. 2006 Jan;26(1):56-60
Insomnia and its comorbidities in chronic kidney disease.
Semin Nephrol. 2006 Jan;26(1):61-3
Sleeping disorders in early chronic kidney disease.
Semin Nephrol. 2006 Jan;26(1):64-7
Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis.
Semin Nephrol. 2006 Jan;26(1):68-79
Continuous monitoring of left ventricle function by VEST in hemodialyzed patients.
Semin Nephrol. 2006 Jan;26(1):80-4